다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Chinese journal of natural medicines = 中國天然藥物, v.12 no.12, 2014년, pp.920 - 928
WANG, Shu-Yuan (Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China) , LIU, Ji-Ping (Department of Pharmacology, Shaanxi University of Chinese Medicine, Xianyang 712046, China) , JI, Wei-Wei (Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China) , CHEN, Wen-Jiao (Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China) , FU, Qiang (Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China) , FENG, Liang (Key Laboratory of Delivery Systems of Chinese Materia Medica, Jiangsu Provincial Academy of Chinese Medicine, Nanjing 210028, China) , MA, Shi-Ping (Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 210009, China)
AI-Helper
Abstract Qifu-Yin (QFY), a widely used formula of traditional Chinese medicine (TCM) derived from “Jingyue Quanshu”, is one of the most commonly used TCM prescriptions for the clinical treatment of Alzheimer disease. The role of advanced glycation end products (AGEs) and its receptor RA...
Neurobiol Aging Ferretti 33 7 1329 2012 10.1016/j.neurobiolaging.2011.01.007 Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease [J]
JAMA Hebert 273 17 1354 1995 10.1001/jama.1995.03520410048025 Age-specific incidence of Alzheimer's disease in a community population [J]
Neurodegen Dis Manage Yang 3 3 195 2013 10.2217/nmt.13.24 Alzheimer's disease in Taiwan: registration and prevalence [J]
Lancet Neuropathology Group 357 9251 169 2001 10.1016/S0140-6736(00)03589-3 Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) [J]
Brain Nerve Sakai 65 4 461 2013 Aβ immunotherapy for Alzheimer's disease [J]
Lancet Holmes 372 9634 216 2008 10.1016/S0140-6736(08)61075-2 Long-term effects of Abeta42 immunization in Alzheimer's disease: follow-up of a randomized, placebo-controlled phase I trial [J]
Neurology Salloway 73 24 2061 2009 10.1212/WNL.0b013e3181c67808 A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease [J]
Neurol Rev Lauren 20 11 16 2012 Bapineuzumab does not show clinical benefit in treating Alzheimer's Disease [J]
Immunotherapy Panza 2 6 767 2010 10.2217/imt.10.80 Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease [J]
Alzheimer's Dementia Martin 8 4 261 2012 10.1016/j.jalz.2011.09.224 Safety and biomarker effects of solanezumab in patients with Alzheimer's disease [J]
J Pharmacol Exp Ther Lee 321 823 2007 10.1124/jpet.106.114009 Amyloid-beta in Alzheimer's disease: The null versus the alternate hypotheses [J]
Brain Res Rev Munch 23 134 1997 10.1016/S0165-0173(96)00016-1 Advanced glycation endproducts in ageing and Alzheimer's disease [J]
Proc Natl Acad Sci USA Smith 91 5710 1994 10.1073/pnas.91.12.5710 Advanced Maillard reaction end products are associated with Alzheimer disease pathology [J]
Am J Pathol Sasaki 153 1149 1998 10.1016/S0002-9440(10)65659-3 Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases [J]
J Pathol Vicente 221 1 13 2010 10.1002/path.2682 The sour side of neurodegenerative disorders: the effects of protein glycation [J]
Biochim Biophys Acta Munch 1360 1 17 1997 10.1016/S0925-4439(96)00062-2 Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide [J]
Prog Biochem Biophys Yin 39 8 747 2012 10.3724/SP.J.1206.2012.00316 Carbonyl stress, aging mechanisms, and the up-stream molecular etiology of Alzheimer's disease [J]
Cytokine Berbaum 41 3 198 2008 10.1016/j.cyto.2007.11.012 Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array [J]
J Neurochem Dukic-Stefanovic 87 1 44 2003 10.1046/j.1471-4159.2003.01988.x Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs) [J]
Antioxid Redox Signal Wang 19 17 2024 2013 10.1089/ars.2012.5158 Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-kappa;B pathway in a transgenic mouse model of Alzheimer's disease [J]
FASEB J Fang 24 4 1043 2010 10.1096/fj.09-139634 RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease [J]
Neurobiol Aging Li 33 7 1400 2012 10.1016/j.neurobiolaging.2011.02.003 AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation [J]
Neurosci Lett Wang 487 1 70 2010 10.1016/j.neulet.2010.09.076 Anti-neuroinflammation effect of ginsenoside Rb1 in a rat model of Alzheimer's disease [J]
PLoS One Quan 8 3 e59155 2013 10.1371/journal.pone.0059155 Ginsenoside Rg1 decreases Aβ1-42 level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease [J]
Neurochem Int Liang 55 8 741 2009 10.1016/j.neuint.2009.07.004 Catalpol protects primary cultured cortical neurons induced by Aβ1-42 through a mitochondrial-dependent caspase pathway [J]
Ding GL, Li SB, Zhang WS, et al. Freeze-dried Rehmannia glutinosa for treating Alzheimer's disease [P]. Faming Zhuanli Shenqing, 2013, CN 103055018, A 20130424.
Inflammation Baek 35 4 1232 2012 10.1007/s10753-012-9433-x Rehmannia glutinosa suppresses inflammatory responses elicited by advanced glycation end products [J]
Chin J Exp Tradit Med Form Sun 17 5 255 2011 Study on active compositions, pharmacological effects and molecular mechanisms of Angelica sinensis in Alzheimer's disease [J]
J Neurosci Res Zhang 89 3 437 2011 10.1002/jnr.22563 Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons [J]
J Ethnopharmacol Feng 148 1 27 2013 10.1016/j.jep.2013.03.035 Protection of glycyrrhizic acid against AGEs-induced endothelial dysfunction through inhibiting RAGE/NF-kappa;B pathway activation in human umbilical vein endothelial cells [J]
Paxinos 1998 The Rat Hippocampus in Stereotaxic Coordinates [M]
Brain Res Lan 1498 9 2013 10.1016/j.brainres.2012.12.040 Paeoniflorin attenuates amyloid-beta peptide-induced neurotoxicity by ameliorating oxidative stress and regulating the NGF-mediated signaling in rats [J]
J Ethnopharmacol Lan 141 386 2012 10.1016/j.jep.2012.02.050 Danggui-Shaoyao-San ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in d-galactose-induced senescent mice [J]
J Med Food Liu 16 7 577 2013 10.1089/jmf.2012.2654 Hypoglycemic and antioxidant activities of paeonol and its beneficial effect on diabetic encephalopathy in streptozotocin-induced diabetic 2 rats [J]
Future Neurol Cavanagh 6 6 757 2011 10.2217/fnl.11.50 Early molecular and synaptic dysfunctions in the prodromal stages of Alzheimer's disease: focus on TNF-α and IL-1β [J]
Future Neurol Lue 4 2 167 2009 10.2217/14796708.4.2.167 Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases [J]
Prog Neurobiol Salminen 87 181 2009 10.1016/j.pneurobio.2009.01.001 Inflammation in Alzheimer's disease: amyloid-[beta] oligomers trigger innate immunity defence via pattern recognition receptors [J]
Neurobiol Aging Srikanth 32 763 2011 10.1016/j.neurobiolaging.2009.04.016 Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease [J]
Cereb Cortex Luth 15 211 2005 10.1093/cercor/bhh123 Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains [J]
Brain Res Wong 920 1-2 32 2001 10.1016/S0006-8993(01)02872-4 Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease [J]
FEBS Lett Neumann 453 283 1999 10.1016/S0014-5793(99)00731-0 High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression [J]
Exp Diabetes Res Win 894605 2012 Regulation of RAGE for attenuating progression of diabetic vascular complications [J]
J Alzheimers Dis Yoshiyama 22 1 295 2010 10.3233/JAD-2010-100681 Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model [J]
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.